SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Corporation Release: First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated With ICS/LABA Published in The New England Journal of Medicine